A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is
Colorectal cancer is the third most common cancer and the third leading cause of cancer death in the United States (1). Moreover, approximately 20% of patients are diagnosed with synchronous colorectal liver metastases (CRLMs)(2). For patients with CRLM, the 5-year survival rate with after chemotherapy alone is approximately 11 percent (3). However, the 5-year and 10-year survival rates after surgical resection are reported as 38% and 26%, respectively (4). Therefore, surgery is considered adoi:10.21614/sgo-25-1-4 fatcat:aqsltznadrgbba5tx7ldvmrh6a